Adedokun George, Sidhu Gurjit, Alipanah Morteza, Wang Gary P, Fan Z Hugh
Interdisciplinary Microsystems Group, Department of Mechanical & Aerospace Engineering, University of Florida, Gainesville, FL, 32611, USA.
Division of Infectious Diseases and Global Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, FL, 32610, USA.
Microsyst Nanoeng. 2024 Nov 29;10(1):181. doi: 10.1038/s41378-024-00822-1.
Early and accurate diagnosis of human immunodeficiency virus (HIV) infection is essential for timely initiation of antiretroviral therapy (ART) and prevention of new infections. However, conventional nucleic-acid-based tests for HIV detection require sophisticated laboratory equipment and trained personnel, which are often unavailable at the point-of-care (POC) or unaffordable in resource-limited settings. We report our development of a low-cost, integrated platform for POC testing of HIV. The platform integrates viral nucleic acid extraction on a paper substrate and reverse transcription loop-mediated isothermal amplification (RT-LAMP) in a portable, battery-powered heating device with real-time detection. The platform does not require laboratory infrastructure such as power outlets. The assay showed a detection limit of 30 copies/mL of HIV RNA in 140 μL human serum or 4 copies/reaction using 50 μL human serum, with no cross-reactivity with hepatitis C virus (HCV). We validated the platform using both plasma samples spiked with HIV and clinical samples from HIV-positive individuals, and compared it with standard laboratory assays based on polymerase chain reaction (PCR). These results demonstrate the feasibility of our platform for HIV testing at the POC.
人类免疫缺陷病毒(HIV)感染的早期准确诊断对于及时启动抗逆转录病毒疗法(ART)和预防新感染至关重要。然而,传统的基于核酸的HIV检测方法需要精密的实验室设备和经过培训的人员,而这些在即时检测(POC)点往往无法获得,或者在资源有限的环境中成本过高。我们报告了我们开发的一种用于HIV即时检测的低成本集成平台。该平台将纸质基质上的病毒核酸提取与逆转录环介导等温扩增(RT-LAMP)集成在一个便携式、电池供电的加热装置中,并进行实时检测。该平台不需要诸如电源插座等实验室基础设施。该检测方法在140μL人血清中的HIV RNA检测限为30拷贝/mL,或使用50μL人血清时为4拷贝/反应,与丙型肝炎病毒(HCV)无交叉反应。我们使用加有HIV的血浆样本和HIV阳性个体的临床样本对该平台进行了验证,并将其与基于聚合酶链反应(PCR)的标准实验室检测方法进行了比较。这些结果证明了我们的平台在即时检测点进行HIV检测的可行性。